Actively Recruiting
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
Led by Ruijin Hospital · Updated on 2025-01-27
4000
Participants Needed
1
Research Sites
865 weeks
Total Duration
On this page
Sponsors
R
Ruijin Hospital
Lead Sponsor
Q
Qilu Hospital of Shandong University
Collaborating Sponsor
AI-Summary
What this Trial Is About
To develop a novel method for evaluating treatment response in lymphoma by utilizing PET/CT imaging data from patients with high-metabolic lymphoma. This involves comparing end-of-treatment PET (EOT-PET) with interim PET (iPET) results to establish a new response assessment approach. The aim is to contrast this method with the Lugano classification criteria, providing clinicians with more scientific and accurate tools for response evaluation and prognosis prediction.
CONDITIONS
Official Title
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histopathologically confirmed high-metabolic lymphoma
- Underwent 18F-FDG PET/CT imaging before, during, and after treatment
- Treated with a standard first-line therapeutic regimen according to lymphoma treatment guidelines and individualized patient-specific considerations
- Complete clinicopathological and follow-up data available
You will not qualify if you...
- History of prior antitumor treatment
- History of other malignancies
- Incomplete clinical data or imaging records
- Presence of other concurrent malignant tumors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
R
Rui Guo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here